• Jaguar Health received Nasdaq Hearings Panel approval for an extension to regain compliance with Nasdaq listing standards, reducing near-term delisting risk but keeping pressure on share-price performance.
• Panel decision reset timeline to meet $1 minimum bid-price rule, setting May 18, 2026 deadline to post a closing bid of at least $1 for 10 consecutive business days.
• Non-compliance notice also cited failure to meet minimum 500,000 publicly held shares requirement, later cured on May 4, 2026 following exercise of pre-funded warrants.
• Failure to meet bid-price requirement by deadline would leave shares subject to delisting from Nasdaq.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-211545), on May 07, 2026, and is solely responsible for the information contained therein.